Antacid and breath freshening composition
An antacid and breath freshening composition comprising a dose effective antacid, and uncomplexed cyclodextrin is provided. The cyclodextrin may be selected from the group containing alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextrin, derivatives thereof and mixtures thereof. The composition is used for the concurrent treatment of various gastro-intestinal conditions and treatment of meal induced halitosis. There is further provided a cooling composition which can be used in orally administered compositions containing gastrointestinal actives to provide an additional sensation of relief to the throat and esophagus.
1 . An oral composition comprising a dose effective antacid and uncomplexed cyclodextrin.
2 . The composition according to claim 1 wherein the antacid comprises an antacid selected from the group consisting of metal bicarbonates, carbonates, hydroxides and oxides and mixtures thereof.
3 . The composition according to claim 1 wherein the antacid comprises an antacid selected from the group consisting of sodium bicarbonate, sodium citrate, sodium tartrate, sodium acetate, sodium carbonate, sodium polyphosphate, sodium pyrophosphate, disodium hydrogen phosphate, trisodium phosphate, other sodium salts, potassium bicarbonate, potassium polyphosphate, potassium pyrophosphate, dipotassium hydrophosphate, tripotassium phosphate, potassium metaphosphate, other potassium salts, magnesium hydroxide, magnesium lactate, magnesium gluconate, magnesium oxide, magnesium carbonate, magnesium silicate, magnesium trisilicate, magnesium aluminosilicates, other magnesium salts, aluminum hydroxide, aluminum carbonate, aluminum phosphate, aluminum magnesium hydroxide, other aluminum salts, calcium carbonate, calcium acetate, calcium phosphate, calcium glycerophosphate, calcium chloride, calcium hydroxide, calcium lactate, calcium bicarbonate, other calcium salts, bismuth aluminate, bismuth subsalicylate, bismuth carbonate, bismuth subcarbonate, bismuth subgallate, bismuth subnitrate, other bismuth salts and mixtures thereof.
4 . The composition according to claim 1 wherein the cyclodextrin is selected from the group consisting of alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextrin and derivatives thereof and mixtures thereof.
5 . The composition according to claim 1 which is an ingestible and digestible delivery system.
6 . The composition according to claim 5 which is selected from the group consisting of chewable pressed tablets, soft chews, fast-melt tablets, lozenges and dissolvable tablets.
7 . The composition according to claim 1 wherein the antacid is present in an amount of from about 5 mEq.
8 . The composition according to claim 1 wherein the cyclodextrin is present in an amount of from about 5% to 80% by weight.
9 . A method of treating conditions associated with gastrointestinal disorders and meal induced halitosis comprising administration of an effective amount of an oral composition comprising a dose effective antacid and uncomplexed cyclodextrin.
10 . The method according to claim 9 wherein the dose effective antacid agent comprises an antacid selected from the group consisting of metal bicarbonates, carbonates, hydroxides and oxides and mixtures thereof.
11 . The method according to claim 9 wherein the dose effective antacid agent comprises an antacid selected from the group consisting of sodium bicarbonate, sodium citrate, sodium tartrate, sodium acetate, sodium carbonate, sodium polyphosphate, sodium pyrophosphate, disodium hydrogen phosphate, trisodium phosphate, other sodium salts, potassium bicarbonate, potassium polyphosphate, potassium pyrophosphate, dipotassium hydrophosphate, tripotassium phosphate, potassium metaphosphate, other potassium salts, magnesium hydroxide, magnesium lactate, magnesium gluconate, magnesium oxide, magnesium carbonate, magnesium silicate, magnesium trisilicate, magnesium aluminosilicates, other magnesium salts, aluminum hydroxide, aluminum carbonate, aluminum phosphate, aluminum magnesium hydroxide, other aluminum salts, calcium carbonate, calcium acetate, calcium phosphate, calcium glycerophosphate, calcium chloride, calcium hydroxide, calcium lactate, calcium bicarbonate, other calcium salts, bismuth aluminate, bismuth subsalicylate, bismuth carbonate, bismuth subcarbonate, bismuth subgallate, bismuth subnitrate, other bismuth salts and mixtures thereof.
12 . The method according to claim 9 wherein the cyclodextrin is selected from the group consisting of alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextrin and derivatives thereof and mixtures thereof.
13 . The method according to claim 9 wherein the oral composition is an ingestible and digestible oral delivery confectionery composition.
14 . The method according to claim 13 which is selected from the group consisting of chewable pressed tablets, soft chews, fast-melt tablets, lozenges and dissolvable tablets.
15 . The method according to claim 9 wherein the antacid is present in an amount of from about 5 mEQ.
16 . The method according to claim 9 wherein the cyclodextrin is present in an amount of from about 5% to 80% by weight.
17 . An orally consumable composition comprising
(1) one or more gastrointestinal actives and
(2) a cooling composition consisting essentially of
(a) menthol present in an amount of about 0.05 to about 10% by weight,
(b) one or more non-mentholic cooling agent present in an amount of about 0.1 to about 20% by weight, and
(c) a cooling sugar alcohol present in the amount of about 70 to about 99.85% by weight.
18 . The oral composition of claim 17 wherein the cooling composition is present in an amount from about 3% to about 40% by weight of the oral composition.
19 . The oral composition of claim 17 wherein the active is an antacid.
20 . The oral composition of claim 19 further comprising uncomplexed cyclodextrin.
21 . A method of providing a cooling effect to the throat and esophagus by administering the orally consumable composition of claim 17 .
22 . The method of claim 21 wherein the cooling composition is present in an amount from about 3% to about 40% by weight of the oral composition.